IRCT20200623047902N4已完成未知
Bioequivalence study of Tamsulosin 0.4mg manufactured by Sanamed company in healthy volunteers
Sanamed pharma company0 个研究点目标入组 18 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- Male
入选标准
- •General Health (Liver, Heart and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-60 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcoholism and Narcoticism
- •History of allergy to Tamsulosin
研究者
相似试验
尚未招募
Unknown
Investigating the in vivo bioequivalence of Tamsulosin 0.4 mgIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N7Tabriz University of Medical Sciences24
招募中
不适用
Clinical study to compare the in vivo parameters of 2 Tamsulosin 0.4 mg ER Capsule formulationsIRCT20180620040164N28Cosar pharmaceutical Co.24
已完成
不适用
Clinical study to compare the in vivo parameters of 2 Tamsulosin 0.4 mg ER Capsule formulationsIRCT20180620040164N26Dorsa Pharmaceutical Co.24
已完成
1 期
Bioequivalence Study of Tamsulosin 0.4 mg Sustained Release Film-coated TabletsHealthyNCT06558032Dexa Medica Group28
招募中
4 期
Comparative efficacy assessment of Tamsulosin vs. Tamsulosin plus Pentoxifylline in the treatment of LUTS/BPH: A preliminary studyIRCT20210729052012N1Shiraz University of Medical Sciences60